Evidence map›Paper›PMID 41936429›Full record

ArticlePediatric dermatology

Erdafitinib-Induced Flexural Calcinosis Cutis in a Pediatric Patient: A Drug-Specific Side-Effect?

Sara de Benito-Mendieta, Susana Buendía, Lucero Noguera-Morel, Isabel Colmenero, Olga Suárez-Traba, Ángela Hernández-Martín

Abstract readCase Reports
In one paragraph

Article in Pediatric dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sara de Benito-MendietaDepartment of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.ORCID https://orcid.org/0009-0005-0629-9036
Susana BuendíaDepartment of Hemato-Oncology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.ORCID https://orcid.org/0000-0001-5597-7394
Lucero Noguera-MorelDepartment of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.ORCID https://orcid.org/0000-0001-5694-8536
Isabel ColmeneroDepartment of Pathology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.ORCID https://orcid.org/0000-0001-6859-187X
Olga Suárez-TrabaDepartment of Radiology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.ORCID https://orcid.org/0000-0001-9231-3933
Ángela Hernández-MartínDepartment of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.ORCID https://orcid.org/0000-0001-7260-8718

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibroblast growth factor receptor (FGFR) inhibitors are effective in malignancies with FGFR pathway alterations but may disrupt calcium-phosphate metabolism, leading to dermatologic side effects. We report a case of calcinosis cutis presenting as painful flexural plaques in a 16-year-old patient treated with erdafitinib for high-grade glioma. The patient's age, unusual lesion distribution, and spontaneous resolution after drug discontinuation highlight a previously unreported association in pediatrics. Recognizing this potential adverse effect may help avoid unnecessary diagnostic or therapeutic interventions.

Indexed as

Antineoplastic AgentsCalcinosis CutisPyrazolesQuinoxalinesAdolescentBrain NeoplasmsHumansMaleAntineoplastic AgentserdafitinibPyrazolesQuinoxalinescalcinosis cutiscalciumerdacitinibFGFR inhibitorflexuralpediatric

Identifiers

PMID41936429
PMCPMC13422986

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.